Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
Li H, Zeng Z, Cheng J, et al. Int J Chron Obstructive Pulm Dis. 2020;15:57– 67.On page 63, Figures 3 is incorrect, the authors missed to check the correct revised figures were inserted into the manuscript during the revision process.Read the original article
| Published in: | International Journal of COPD |
|---|---|
| Main Authors: | Li H, Zeng Z, Cheng J, Hu G, Li Y, Wei L, Zhou Y, Ran P |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-02-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-prognostic-role-of-nt-probnp-for-in-hospital-and-1-year-mo-peer-reviewed-article-COPD |
Similar Items
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)
by: Andree G. Pearson, et al.
Published: (2025-08-01)
Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)
by: H.M. Kim, et al.
Published: (2020-08-01)
Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)
by: I. A. Kozlov, et al.
Published: (2023-10-01)
Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)
by: Pingfeng Feng, et al.
Published: (2024-07-01)
Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
Role of Serum NT-proBNP Levels in Early Prediction of Prognosis in Severe COVID-19 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
Setting the optimal threshold of NT‐proBNP and BNP for the diagnosis of heart failure in patients over 75 years
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)
by: Maria António, et al.
Published: (2023-07-01)
Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)
by: I. A. Kozlov, et al.
Published: (2023-02-01)
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01)
by: Jinling Ma, et al.
Published: (2025-07-01)
Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients: Findings from the NHANES (1999–2018)
by: Qingping Zeng, et al.
Published: (2024-08-01)
by: Qingping Zeng, et al.
Published: (2024-08-01)
Electrochemical Immunosensor for NT-proBNP Detection in Artificial Human Saliva: Heart Failure Biomedical Application
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
Determining the role of NT-proBNP levels in diabetic patients with heart failure: A study from North India
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
by: Paweł Komarnicki, et al.
Published: (2023-09-01)
by: Paweł Komarnicki, et al.
Published: (2023-09-01)
Prognostic Value of the NT-proBNP-to-Albumin Ratio (NTAR) for In-Hospital Mortality in Chronic Heart Failure Patients
by: Liviu Cristescu, et al.
Published: (2025-08-01)
by: Liviu Cristescu, et al.
Published: (2025-08-01)
GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)
by: Gina Sado, et al.
Published: (2024-12-01)
Assessing hs-Troponin T and NT-proBNP in acute heart failure and cardiorenal syndrome: Diagnostic, prognostic, and functional interrelationships
by: Alredha Redha Dawud Abd, et al.
Published: (2025-09-01)
by: Alredha Redha Dawud Abd, et al.
Published: (2025-09-01)
NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis
by: Cheng He, et al.
Published: (2025-10-01)
by: Cheng He, et al.
Published: (2025-10-01)
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)
by: Syeda Humayra, et al.
Published: (2025-04-01)
Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)
by: Jie Zhang, et al.
Published: (2017-03-01)
Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
by: Yi Peng, et al.
Published: (2022-06-01)
by: Yi Peng, et al.
Published: (2022-06-01)
Role of dietary inflammatory index in the association of NT-proBNP with all-cause and cardiovascular mortality in NHANES 1999–2004
by: Lihua Xie, et al.
Published: (2024-08-01)
by: Lihua Xie, et al.
Published: (2024-08-01)
Correlation between NT-proBNP, hsCRP and OXSR1: Clinical relevance in evaluating the prognosis of polytrauma patients
by: Costin Dumitru, et al.
Published: (2021-09-01)
by: Costin Dumitru, et al.
Published: (2021-09-01)
NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis
by: Evangelos Christou, et al.
Published: (2022-06-01)
by: Evangelos Christou, et al.
Published: (2022-06-01)
The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)
by: Aidonis Rammos, et al.
Published: (2023-08-01)
Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
by: Kanako Teramoto, et al.
Published: (2024-05-01)
by: Kanako Teramoto, et al.
Published: (2024-05-01)
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)
Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)
by: Narmin Akif Azizova
Published: (2024-11-01)
NT‐proBNP Mediates the Association Between FGF23 and All‐Cause Mortality in Individuals With Type 2 Diabetes
by: Amarens van der Vaart, et al.
Published: (2023-12-01)
by: Amarens van der Vaart, et al.
Published: (2023-12-01)
Right Ventricular Strain and Left Ventricular Strain Using Speckle Tracking Echocardiography—Independent Prognostic Associations in COPD Alongside NT-proBNP
by: Silvana-Elena Hojda, et al.
Published: (2025-10-01)
by: Silvana-Elena Hojda, et al.
Published: (2025-10-01)
Evaluation of in-Hospital NT-ProBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)
NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)
by: Claire Sweeney, et al.
Published: (2021-12-01)
Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS-
by: Akira Suda, et al.
Published: (2022-12-01)
by: Akira Suda, et al.
Published: (2022-12-01)
The Changes of Amino Terminal Pro B-type Natriuretic Peptide (NT-proBNP) Concentration and Left Ventricular Ejection Fraction on Doxorubicin Chemotherapy Patients
by: Telly Kamelia, et al.
Published: (2017-06-01)
by: Telly Kamelia, et al.
Published: (2017-06-01)
Changes in Cardiac Levels of Caspase-8, Bcl-2 and NT-proBNP Following 4 Weeks of Aerobic Exercise in Diabetic Rats
by: Saeid Tanoorsaz, et al.
Published: (2017-12-01)
by: Saeid Tanoorsaz, et al.
Published: (2017-12-01)
Similar Items
-
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01) -
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01) -
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01) -
Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)
